相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A PBPK model for evaluating the impact of aldehyde dehydrogenase polymorphisms on comparative rat and human nasal tissue acetaldehyde dosimetry
Justin G. Teeguarden et al.
INHALATION TOXICOLOGY (2008)
N-acetyltransferase 1 in colon and rectal cancer cases from an industrialized area
Hermann C. Roemer et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES (2008)
The influence of polymorphisms of glutathione S-transferases M1 and M3 on the development of human urothelial cancer
Klaus Golka et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES (2008)
UDP-glucuronosyltransferase 2B7 C802T (His(268)Tyr) polymorphism in bladder cancer cases
Anna Zimmermann et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES (2008)
N-acetyltransferase-2 and medical history in bladder cancer cases with a suspected occupational disease (BK 1301) Germany
Wobbeke Weistenhoefer et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES (2008)
Improved Understanding of Genetic and Genomic Influences on Drug Disposition and Action
Denise Avard et al.
PEDIATRIC DRUGS (2008)
Role of the genetic polymorphisms in the 5 '-flanking region for transcriptional regulation of the human CYP2E1 gene
Takayuki Uchimoto et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2007)
Impaired expression of CYP2D6 in intermediate metabolizers carrying the *41 allele caused by the intronic SNP 2988G>A:: evidence for modulation of splicing events
Claudia Toscano et al.
PHARMACOGENETICS AND GENOMICS (2006)
Relevance of the deletion polymorphisms of the glutathione S-transferases GSTT1 and GSTM1 in pharmacology and toxicology
H. M. Bolt et al.
CURRENT DRUG METABOLISM (2006)
Genetic basis of toxic reactions to drugs and chemicals
I Cascorbi
TOXICOLOGY LETTERS (2006)
N-acetyltransferase 2 genetic polymorphism:: effects of carcinogen and haplotype on urinary bladder cancer risk
DW Hein
ONCOGENE (2006)
Association of ALDH2 polymorphism with sensitivity to acetaldehyde-induced micronuclei and facial flushing after alcohol intake
JS Kim et al.
TOXICOLOGY (2005)
Modulation of paraoxonase (PON1) activity
LG Costa et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity
M Ingelman-Sundberg
PHARMACOGENOMICS JOURNAL (2005)
A novel intronic mutation, 2988G>A, with high predictivity for impaired function of cytochrome P450 2D6 in white subjects
S Raimundo et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry
UM Zanger et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2004)
Pharmacogenetics of cytochrome P4502D6: genetic background and clinical implication
I Cascorbi
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2003)
Increased influence of genetic variation on PON1 activity in neonates
J Chen et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2003)
Markers of genetic susceptibility in human environmental hygiene and toxicology:: The role of selected CYP, NAT and GST genes
R Thier et al.
INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH (2003)
Functional characterization of three human cytochrome P450 2E1 variants with amino acid substitutions
N Hanioka et al.
XENOBIOTICA (2003)
The impact of cytochrome P450 2E1-dependent metabolic variance on a risk-relevant pharmacokinetic outcome in humans
JC Lipscomb et al.
RISK ANALYSIS (2003)
Population distribution of aldehyde dehydrogenase-2 genetic polymorphism: Implications for risk assessment
G Ginsberg et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2002)
An approach for the quantitative consideration of genetic polymorphism data in chemical risk assessment: Examples with warfarin and parathion
PR Gentry et al.
TOXICOLOGICAL SCIENCES (2002)
Genetic polymorphisms of glutathione S-transferases as modulators of lung cancer susceptibility
I Stücker et al.
CARCINOGENESIS (2002)
Incorporating human interindividual biotransformation variance in health risk assessment
JC Lipscomb et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2002)
Genetic Polymorphisms in assessing interindividual variability in delivered dose
LT Haber et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2002)
Association between genetic polymorphisms and biomarkers in styrene-exposed workers
P Vodicka et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2001)
Influence of polymorphisms of the human glutathione transferases and cytochrome P450 2E1 enzyme on the metabolism and toxicity of ethylene oxide and acrylonitrile
R Thier et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2001)
Polymorphism of xenobiotic-metabolizing enzymes and excretion of styrene-specific mercapturic acids
G De Palma et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2001)
A Bayesian analysis of the influence of GSTT1 polymorphism on the cancer risk estimate for dichloromethane
F Jonsson et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2001)
Ethnic and genetic differences in metabolism genes and risk of toxicity and cancer
DW Nebert et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2001)
Genetic variability in susceptibility and response to toxicants
MC Miller et al.
TOXICOLOGY LETTERS (2001)
Alcohol and aldehyde dehydrogenase gene polymorphisms and oropharyngolaryngeal, esophageal and stomach cancers in Japanese alcoholics
A Yokoyama et al.
CARCINOGENESIS (2001)
Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds
WF Li et al.
PHARMACOGENETICS (2000)
Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1192 or PON155 genotype
GP Jarvik et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Mammalian class theta GST and differential susceptibility to carcinogens: a review
S Landi
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2000)
Evidence for the activation of organophosphate pesticides by cytochromes P450 3A4 and 2D6 in human liver microsomes
C Sams et al.
TOXICOLOGY LETTERS (2000)
Characterization of the glutathione S-transferase GSTT1 deletion:: discrimination of all genotypes by polymerase chain reaction indicates a trimodular genotype-phenotype correlation
R Sprenger et al.
PHARMACOGENETICS (2000)
Aldehyde dehydrogenase (ALDH) 2 associates with oxidation of methoxyacetaldehyde;: in vitro analysis with liver subcellular fraction derived from human and Aldh2 gene targeting mouse
K Kitagawa et al.
FEBS LETTERS (2000)
Analysis of paraoxonase (PON1) L55M status requires both genotype and phenotype
VH Brophy et al.
PHARMACOGENETICS (2000)
Polymorphism of drug-metabolizing enzymes in relation to individual susceptibility to industrial chemicals
T Nakajima et al.
INDUSTRIAL HEALTH (2000)
XPD polymorphisms: effects on DNA repair proficiency
RM Lunn et al.
CARCINOGENESIS (2000)
Polymorphisms of human aldehyde dehydrogenases - Consequences for drug metabolism and disease
V Vasiliou et al.
PHARMACOLOGY (2000)
分享论文
